Cross-sectional study reveals the impact and prevalence of dual sensory impairment in older adults, indicating crucial health concerns.
We aimed to determine the prevalence, risk factors, patient-centered impact and health-related costs of three types of dual sensory impairment (DSI) in a multi-ethnic older Asian population. In this population-based, cross-sectional study (2017–2022) of 2048 Asian adults aged ≥ 60 years, vision, hearing and olfactory impairments (VI, HI and OI) were assessed using validated clinical tests. DSI types included: VI + HI, VI + OI, and HI + OI. Age-, sex-, and ethnicity-adjusted prevalence rates (2020 Singapore Census) were calculated. Regression analyses identified associated risk factors, impacts and healthcare costs. Of the 2048 participants (mean age ± standard deviation 75.7 ± 7; 49.5% female), prevalence rates of VI + OI, VI + HI, OI + HI were 1.0%, 7.3% and 21.7%, respectively. Older age (odds ratio[OR]1.22) and multimorbidity (OR3.74) were significantly associated with VI + HI, while older age (OR1.23), males (OR3.62), living alone (OR2.37) and current smoking (OR2.51) were associated with higher odds of OI + HI. VI + HI was associated with lower HRQoL-scores (β:− 0.026), while VI + HI (OR2.39) and OI + HI (OR2.10) were associated with lower IADL status. The OI + HI group showed a trend toward higher healthcare costs compared to those without. DSI, particularly OI + HI, is relatively prevalent in older Singaporean adults. Early identification and targeted screening of at-risk groups may mitigate adverse outcomes and healthcare cost, given the global ageing population.
No takes yet. Share an insight, caveat, or question.
Nooteboom et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: